Company / Free Cash Flow per Share
Merck & Co. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$4.85
FY2025
5-year range
$3.36 / $7.12
FY2021-FY2025
Trend
-31.8%
vs FY2024
Sector context
#20 of 192
Health Care
What the data says
Among 192 Health Care companies, Merck & Co. is in the top 10% for free cash flow per share. Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $1.61 in FY2017 to $7.12 in FY2024.
Based on SEC 10-K filings.
4.85 in FY2025 with a 5-year CAGR of +17.4%. Top quartile in the Health Care sector.
Improved from $3.60 to $4.85 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -5.7%
- 5-Year CAGR
- +17.4%
- 10-Year CAGR
- -
Sector benchmark
+124.5% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 31.8% year-over-year.
- Ranks #20 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2024.
- Lowest free cash flow per share in the period was in FY2017.
Company context
Key Data Points
- Strong profit margin: 29.6%
- Strong return on equity: 36.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.85 | -31.8% |
| FY2024 | $7.12 | +97.6% |
| FY2023 | $3.60 | -37.8% |
| FY2022 | $5.79 | +72.2% |
| FY2021 | $3.36 | +54.7% |
| FY2020 | $2.17 | -40.7% |
| FY2019 | $3.66 | +23.0% |
| FY2018 | $2.98 | +85.6% |
| FY2017 | $1.61 | -46.3% |
| FY2016 | $2.99 | -20.3% |
As of FY2025 · SEC 10-K · Updated Mar 9, 2026